Background Myasthenia gravis is an autoimmune disease in which autoantibodies interfere
with neuromuscular transmission. As with other autoimmune diseases, people with …

More than a decade ago myasthenic symptoms were observed in rabbits immunized with
acetylcholine receptor (AChR){119} and AChR deficiency was found at the neuromuscular …

Skeletal Muscle: Form and Function, Second Edition, provides readers with a detailed
understanding of the different facets of muscle physiology. Meticulously researched and …

The decrease of acetylcholine receptors at neuromuscular junctions of myasthenic patients
has been attributed to an antibody-mediated autoimmune process that accelerates receptor …

Sixty patients with myasthenia gravis were examined prospectively by measuring serial titers
of antibodies against human acetylcholine receptor, and these were correlated with a …

3 3.1 2. Insertion into plasma membrane 308 3.3 1.3. Steps m biosynthetic pathway at which
control may be exerted 309 3.3 1.4. Post-translational modifications 309 3.3. 2. Receptor …

Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies that are either
directed to the muscle nicotinic acetylcholine receptor (AChR) or to the muscle-specific …

Experimental autoimmune myasthenia gravis (EAMG) is an animal model of human
myasthenia gravis (MG). In mice, EAMG is induced by immunization with Torpedo californica …

Plasma exchange produces a short-term clinical improvement in myasthenia gravis (MG)
which may be attributable to removal of acetylcholine receptor (AChR) antibody. The …

Objectives–To evaluate the efficacy and safety of one single intravenous
methylprednisolone (IVMP) pulse therapy in myasthenia gravis. Material and methods–We …